• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中巨噬细胞- T 细胞相互作用的多尺度建模。

Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment.

机构信息

Department of Biomedical Engineering, University of Southern California, Los Angeles, California, United States of America.

Department of Quantitative and Biological Sciences, University of Southern California, Los Angeles, California, United States of America.

出版信息

PLoS Comput Biol. 2020 Dec 23;16(12):e1008519. doi: 10.1371/journal.pcbi.1008519. eCollection 2020 Dec.

DOI:10.1371/journal.pcbi.1008519
PMID:33362239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7790427/
Abstract

Within the tumor microenvironment, macrophages exist in an immunosuppressive state, preventing T cells from eliminating the tumor. Due to this, research is focusing on immunotherapies that specifically target macrophages in order to reduce their immunosuppressive capabilities and promote T cell function. In this study, we develop an agent-based model consisting of the interactions between macrophages, T cells, and tumor cells to determine how the immune response changes due to three macrophage-based immunotherapeutic strategies: macrophage depletion, recruitment inhibition, and macrophage reeducation. We find that reeducation, which converts the macrophages into an immune-promoting phenotype, is the most effective strategy and that the macrophage recruitment rate and tumor proliferation rate (tumor-specific properties) have large impacts on therapy efficacy. We also employ a novel method of using a neural network to reduce the computational complexity of an intracellular signaling mechanistic model.

摘要

在肿瘤微环境中,巨噬细胞处于免疫抑制状态,阻止 T 细胞消除肿瘤。因此,研究人员专注于免疫疗法,专门针对巨噬细胞,以降低其免疫抑制能力并促进 T 细胞功能。在这项研究中,我们开发了一个基于代理的模型,其中包括巨噬细胞、T 细胞和肿瘤细胞之间的相互作用,以确定由于三种基于巨噬细胞的免疫治疗策略(巨噬细胞耗竭、募集抑制和巨噬细胞再教育),免疫反应如何变化。我们发现,再教育将巨噬细胞转化为促进免疫的表型是最有效的策略,并且巨噬细胞募集率和肿瘤增殖率(肿瘤特异性特性)对治疗效果有很大影响。我们还采用了一种使用神经网络的新方法来降低细胞内信号转导机制模型的计算复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/b6327413ce65/pcbi.1008519.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/a7203ff74c3b/pcbi.1008519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/fde4ff012e77/pcbi.1008519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/e3209b058675/pcbi.1008519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/0f0896f8ae85/pcbi.1008519.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/c061e045cb17/pcbi.1008519.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/8c88b4cefb61/pcbi.1008519.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/ef02bf2902f3/pcbi.1008519.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/1d2a0a077f0c/pcbi.1008519.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/5a0e72afd2d8/pcbi.1008519.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/c80a4958299b/pcbi.1008519.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/d24daeffed0c/pcbi.1008519.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/b6327413ce65/pcbi.1008519.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/a7203ff74c3b/pcbi.1008519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/fde4ff012e77/pcbi.1008519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/e3209b058675/pcbi.1008519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/0f0896f8ae85/pcbi.1008519.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/c061e045cb17/pcbi.1008519.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/8c88b4cefb61/pcbi.1008519.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/ef02bf2902f3/pcbi.1008519.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/1d2a0a077f0c/pcbi.1008519.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/5a0e72afd2d8/pcbi.1008519.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/c80a4958299b/pcbi.1008519.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/d24daeffed0c/pcbi.1008519.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab5b/7790427/b6327413ce65/pcbi.1008519.g012.jpg

相似文献

1
Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment.肿瘤微环境中巨噬细胞- T 细胞相互作用的多尺度建模。
PLoS Comput Biol. 2020 Dec 23;16(12):e1008519. doi: 10.1371/journal.pcbi.1008519. eCollection 2020 Dec.
2
Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.肿瘤对肝转移微环境中巨噬细胞和 T 淋巴细胞相互作用的反应建模。
Cancer Immunol Immunother. 2021 May;70(5):1475-1488. doi: 10.1007/s00262-020-02785-4. Epub 2020 Nov 12.
3
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.肿瘤细胞释放的自噬体(TRAPs)通过诱导 PD-L1 表达增加的 M2 样巨噬细胞促进免疫抑制。
J Immunother Cancer. 2018 Dec 18;6(1):151. doi: 10.1186/s40425-018-0452-5.
4
Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.抗 PD-L1 治疗导致巨噬细胞区室的功能重塑。
Cancer Res. 2019 Apr 1;79(7):1493-1506. doi: 10.1158/0008-5472.CAN-18-3208. Epub 2019 Jan 24.
5
Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment.肿瘤相关巨噬细胞与癌症微环境相互作用的数学建模。
J Immunother Cancer. 2018 Jan 30;6(1):10. doi: 10.1186/s40425-017-0313-7.
6
Macrophage targeting in cancer.肿瘤中的巨噬细胞靶向治疗。
Ann N Y Acad Sci. 2021 Sep;1499(1):18-41. doi: 10.1111/nyas.14377. Epub 2020 May 22.
7
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.突破障碍:基于 T 细胞的癌症免疫疗法的进展。
Front Immunol. 2021 Nov 18;12:777073. doi: 10.3389/fimmu.2021.777073. eCollection 2021.
8
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.双价和三价 T 细胞衔接器在癌症患者样本中耗尽肿瘤相关巨噬细胞。
J Immunother Cancer. 2019 Nov 21;7(1):320. doi: 10.1186/s40425-019-0807-6.
9
Modeling immune cell behavior across scales in cancer.癌症中跨尺度免疫细胞行为建模。
Wiley Interdiscip Rev Syst Biol Med. 2020 Jul;12(4):e1484. doi: 10.1002/wsbm.1484. Epub 2020 Mar 4.
10
Blocking LTB signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy.黄连阻断 LTB 信号介导的 TAMs 募集作用可增强肺癌对免疫治疗的敏感性。
Phytomedicine. 2023 Oct;119:154968. doi: 10.1016/j.phymed.2023.154968. Epub 2023 Jul 22.

引用本文的文献

1
Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow.人工智能与机器学习在疫苗和免疫疗法研发中的应用——过去、现在与未来
Front Artif Intell. 2025 Jul 18;8:1620572. doi: 10.3389/frai.2025.1620572. eCollection 2025.
2
Biomimetic mineralized DCPA/ anti-CD47 containing thermo-sensitive injectable hydrogel for bone-metastatic prostate cancer treatment.用于骨转移性前列腺癌治疗的含仿生矿化磷酸二钙/抗CD47的热敏可注射水凝胶
Mater Today Bio. 2025 Feb 11;31:101573. doi: 10.1016/j.mtbio.2025.101573. eCollection 2025 Apr.
3
Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.

本文引用的文献

1
A review of cancer immunotherapy: from the past, to the present, to the future.癌症免疫疗法综述:从过去到现在,到未来。
Curr Oncol. 2020 Apr;27(Suppl 2):S87-S97. doi: 10.3747/co.27.5223. Epub 2020 Apr 1.
2
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy.下一代免疫肿瘤学药物:癌症免疫治疗中的当前动力转变。
J Hematol Oncol. 2020 Apr 3;13(1):29. doi: 10.1186/s13045-020-00862-w.
3
Modeling immune cell behavior across scales in cancer.癌症中跨尺度免疫细胞行为建模。
脑肿瘤多组学数据的网络分析揭示了改变细胞状态转变的药理学机会。
NPJ Syst Biol Appl. 2025 Feb 1;11(1):14. doi: 10.1038/s41540-025-00493-2.
4
Mathematical models of intercellular signaling in breast cancer.乳腺癌细胞间信号传导的数学模型
Semin Cancer Biol. 2025 Feb;109:91-100. doi: 10.1016/j.semcancer.2025.01.005. Epub 2025 Jan 29.
5
Spatial organization and stochastic fluctuations of immune cells impact clinical responsiveness to immunotherapy in melanoma patients.免疫细胞的空间组织和随机波动影响黑色素瘤患者对免疫疗法的临床反应。
PNAS Nexus. 2024 Nov 26;3(12):pgae539. doi: 10.1093/pnasnexus/pgae539. eCollection 2024 Dec.
6
A multiscale model of immune surveillance in micrometastases gives insights on cancer patient digital twins.微转移中免疫监视的多尺度模型为癌症患者数字孪生提供了见解。
NPJ Syst Biol Appl. 2024 Dec 4;10(1):144. doi: 10.1038/s41540-024-00472-z.
7
Towards verifiable cancer digital twins: tissue level modeling protocol for precision medicine.迈向可验证的癌症数字孪生:精准医学的组织水平建模协议
Front Physiol. 2024 Oct 23;15:1473125. doi: 10.3389/fphys.2024.1473125. eCollection 2024.
8
Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization.黑色素瘤和细胞外囊泡中的程序性死亡配体-1通过M2样巨噬细胞极化促进局部和区域免疫抑制。
Am J Pathol. 2025 Feb;195(2):306-320. doi: 10.1016/j.ajpath.2024.09.011. Epub 2024 Oct 29.
9
Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions.将基于机制的T细胞表型整合到肿瘤-免疫细胞相互作用模型中。
APL Bioeng. 2024 Aug 20;8(3):036111. doi: 10.1063/5.0205996. eCollection 2024 Sep.
10
M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy.M1极化巨噬细胞衍生的细胞纳米囊泡包被的脂质纳米颗粒,通过基因治疗与癌症免疫治疗的杂交增强癌症治疗效果。
Acta Pharm Sin B. 2024 Jul;14(7):3169-3183. doi: 10.1016/j.apsb.2024.03.004. Epub 2024 Mar 7.
Wiley Interdiscip Rev Syst Biol Med. 2020 Jul;12(4):e1484. doi: 10.1002/wsbm.1484. Epub 2020 Mar 4.
4
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice.评估人癌组织中肿瘤相关巨噬细胞向M1和M2表型的极化:常规临床实践中的技术细节与挑战
Front Oncol. 2020 Jan 24;9:1512. doi: 10.3389/fonc.2019.01512. eCollection 2019.
5
Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity.基于数据驱动的嵌合抗原受体T细胞信号传导机制模型分析预测细胞间异质性的影响。
J Theor Biol. 2020 Mar 21;489:110125. doi: 10.1016/j.jtbi.2019.110125. Epub 2019 Dec 19.
6
Harnessing tumor-associated macrophages as aids for cancer immunotherapy.利用肿瘤相关巨噬细胞作为癌症免疫治疗的辅助手段。
Mol Cancer. 2019 Dec 5;18(1):177. doi: 10.1186/s12943-019-1102-3.
7
A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology.一种巨噬细胞极化的机制整合计算模型:对人类病理生理学的影响。
PLoS Comput Biol. 2019 Nov 18;15(11):e1007468. doi: 10.1371/journal.pcbi.1007468. eCollection 2019 Nov.
8
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.酸性通过改变前列腺癌中的巨噬细胞表型促进肿瘤进展。
Br J Cancer. 2019 Oct;121(7):556-566. doi: 10.1038/s41416-019-0542-2. Epub 2019 Aug 16.
9
Clonal replacement of tumor-specific T cells following PD-1 blockade.PD-1 阻断后肿瘤特异性 T 细胞的克隆性替换。
Nat Med. 2019 Aug;25(8):1251-1259. doi: 10.1038/s41591-019-0522-3. Epub 2019 Jul 29.
10
Macrophages as regulators of tumour immunity and immunotherapy.巨噬细胞作为肿瘤免疫和免疫治疗的调节剂。
Nat Rev Immunol. 2019 Jun;19(6):369-382. doi: 10.1038/s41577-019-0127-6.